Depression
From the Journals
Arthritis prevalent in older adults with any degree of depression
Older patients with depressive symptoms should be screened for arthritis-related pain.
Conference Coverage
Transgender health survey provides data on nearly 28,000 individuals
WASHINGTON – The 2015 U.S. Transgender Survey provides more data on transgender life and health than ever previously available.
From the Journals
Guidelines released for perimenopausal depression
The risk of perimenopausal depression is estimated to be 45%-68%.
What Your Patients are Hearing
Survivors of sexual abuse cope with stigma
People victimized by Roman Catholic priests describe ostracism from fellow parishioners.
From the Journals
Female to male transgender teens most likely to attempt suicide
Identifying as heterosexual identifying as non-heterosexual was associated with an increased risk of attempting suicide, except in nonbinary...
Sponsored Supplement
Depression Across the Spectrum of Mood Disorders: Advanced Strategies in Major Depressive Disorder and Bipolar Disorder
What Your Patients are Hearing
The aftermath of a mother’s suicide attempt
A mother gets a chance to explain that her suicidal depression was totally separate from her love for her family.
From the Journals
Adults with autism, comorbid depression less likely to get talk therapy
Adults with autism spectrum disorder were more likely to be prescribed different classes of medications at the same time.
MDedge Psychcast
Suma Chand: Cognitive-Behavioral Therapy
Dr. Chand talks about the use of CBT as monotherapy and in combination with antidepressants for acute and long-term treatment of depression. And...
From the Journals
Targeting depression, not eating disorders, may yield better results
People who might not have clinical eating disorders might have body image concerns that place their mental health at risk.
Evidence-Based Reviews
CBT for depression: What the evidence says
Cognitive-behavioral therapy can play an important role in both acute and long-term treatment.
FDA/CDC
Janssen submits NDA for esketamine nasal spray
Esketamine has shown promise in treating refractory depression when used with an oral antidepressant.